Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Anxiety Disorders: full-pipeline trial registry
42 of 85 indexed Anxiety Disorders trials are currently recruiting.
Corpus placement: #165 of 28,707 conditions by registered trial count.
85 US clinical trials · 42 currently recruiting · #165 of 28,707 conditions by registered trial count
Anxiety Disorders: 85 US clinical trials tracked, 42 recruiting.
Anxiety Disorders is the subject of 85 registered US clinical trials on ClinicalTrials.gov, 42 of them currently open to new participants. 10 are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 5 of these trials.
Enrollment posture brief
Registry condition anxiety-disorders
OPEN 42 | RECR 49% | LATE 10 | EARLY 11 | RANK #165 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Metastatic Malignant Solid Neoplasm (49% recruiting · 93 trials)
Anxiety Disorders lists 42 open slots (49% of 85 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Anxiety Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Anxiety Disorders is recruiting above its size-band peers.
42 of 85 indexed trials (49.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Anxiety Disorders trials is spread across many organizations.
Massachusetts General Hospital accounts for 5 of 85 trials (5.9%). 57 distinct sponsors appear on at least one study for this condition label.
-
Typical Anxiety Disorders enrolment sits around 109 participants.
Median target enrolment is 109 among the 85 trials that report a genuine target (sentinel values excluded). 39 of those (45.9%) plan for fewer than 100 participants.
-
Anxiety Disorders research is mostly interventional.
75 interventional and 10 observational studies make up this index (88.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
85 total, page 2 of 2
Testing a Transdiagnostic TMS Treatment Target
Brigham and Women's Hospital
NCT06282146
Harnessing Mobile Technology to Reduce Mental Health Disorders in College Populations
Washington University School of Medicine
NCT04162847
Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression
Rutgers University
NCT01829100
AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)
AstraZeneca
NCT00808249
Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.
AstraZeneca
NCT00314210
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
Eli Lilly and Company
NCT00122850
Telephone-Based Care Management Program for Individuals With Anxiety Disorders
University of Pittsburgh
NCT00158327
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
Boston University Charles River Campus
NCT01243606
A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD
US Department of Veterans Affairs
NCT00105911
School-based Treatment of Anxiety Research Study (STARS)
UConn Health
NCT01761396
Treatment for Specific Phobias in Children
Virginia Polytechnic Institute and State University
NCT00051220
Flourishing and Virtue in Cognitive-Behavioral Therapy for Anxiety and Depressive Disorders
Boston University Charles River Campus
NCT05120232
Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)
Yale University
NCT02310152
Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
University Hospitals Cleveland Medical Center
NCT00671853
Retraining Attention to Treat Alcohol Dependence and Social Anxiety
University of Cincinnati
NCT01886716
Family-Focused CBT Skills App and Standard Self Help Options for Childhood Anxiety
Kansas City Center for Anxiety Treatment, P.A.
NCT03269370
Inhaled Oxytocin and HPA Axis Reactivity
University of North Carolina, Chapel Hill
NCT03593473
Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging
Washington University School of Medicine
NCT01693874
Personalized Feedback for Smokers With Elevated Anxiety Sensitivity
University of Houston
NCT03382093
Feasibility of Collateral Information Review and Its Impact on Clinical Decision-Making
Mclean Hospital
NCT04635748
Reward Processes and Rehearsal in Exposure Therapy
University of California, Los Angeles
NCT06132425
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
Louisiana State University and A&M College
NCT01875796
Transdiagnostic Sleep and Anxiety Treatment
Florida State University
NCT03664310
A Single-Session Intervention for Families on Waitlists for Child Anxiety Treatment
Florida International University
NCT05841680
Anxiety in Older Veterans
VA Office of Research and Development
NCT02400723
Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety
University of Denver
NCT04245501
Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli
Georgetown University
NCT03206437
Evaluating a Personalized Trans-Diagnostic Group Therapy for Anxiety
Stanford University
NCT03457922
Benzodiazepine Taper With Cognitive Behavioral Therapy in Patients Using Prescription Opioids
University of California, Los Angeles
NCT05573906
Relaxation Treatment for Anxiety in Adults Aged 60 or Older
Palo Alto Veterans Institute for Research
NCT02429778
School-based Treatment for Anxious Children
Johns Hopkins University
NCT00536094
Study of Treatment for Opioid Dependence and Anxiety Disorders
Mclean Hospital
NCT02252068
Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
Duke University
NCT00887679
Strategies for Treating Anxiety Research Study
University of Nevada, Las Vegas
NCT05398016
Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
Washington University School of Medicine
NCT01333098
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 6 |
| Phase 3 | 8 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Anxiety Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Anxiety Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Anxiety Disorders page
85 registered trials, 42 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 42 Anxiety Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Massachusetts General Hospital sponsors the most Anxiety Disorders trials on record, review their full trial history before evaluating a specific study. See Massachusetts General Hospital's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Anxiety Disorders condition card totals 85 registered trials; most-linked intervention Mindful Self-Compassion; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.